Showing results (151-160 of 213) with videos related to
Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2020
Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapyOuti Keinänen, Kimberly Fung, James M Brennan, et al.EJNMMI Research|June 12, 2021
Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing miceMarion Chomet, Maxime Schreurs, Ricardo Vos, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 15, 2005
Methylene-azaphosphirane as a reactive intermediateJ Chris Slootweg, Mark J M Vlaar, Danielle J Vugts, et al.Cancer Research|August 23, 2014
Development of novel ADCs: conjugation of tubulysin analogues to trastuzumab monitored by dual radiolabelingRuth Cohen, Danielle J Vugts, Gerard W M Visser, et al.Cancer Research|January 25, 2018
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse ModelsSai Kiran Sharma, Andrew Chow, Sebastien Monette, et al.Nuclear Medicine and Biology|November 26, 2024
New prospects for 89Zr-immuno-PET in brain applications - Alpha-synucleinopathiesThomas E Wuensche, Pedro M Pereira, Albert D Windhorst, et al.Organic Letters|November 3, 2006
Diastereoselective multicomponent synthesis of dihydropyridones with an isocyanide functionalityMonica Paravidino, Robin S Bon, Rachel Scheffelaar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2013
Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patientsDerrek A Heuveling, Annelies van Schie, Danielle J Vugts, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2025
Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy AnalysisRandy Yeh, Fresia Pareja, Parnian Shobeiri, et al.Molecular Pharmaceutics|February 8, 2024
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung CancerSamantha M Sarrett, Cindy Rodriguez, Samantha Delaney, et al.Pageof 22